1. Home
  2. SILO vs LDWY Comparison

SILO vs LDWY Comparison

Compare SILO & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • LDWY
  • Stock Information
  • Founded
  • SILO 2010
  • LDWY 1990
  • Country
  • SILO United States
  • LDWY United States
  • Employees
  • SILO N/A
  • LDWY N/A
  • Industry
  • SILO Apparel
  • LDWY Advertising
  • Sector
  • SILO Consumer Discretionary
  • LDWY Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • SILO 8.8M
  • LDWY 8.2M
  • IPO Year
  • SILO N/A
  • LDWY 1991
  • Fundamental
  • Price
  • SILO $1.66
  • LDWY $4.34
  • Analyst Decision
  • SILO
  • LDWY
  • Analyst Count
  • SILO 0
  • LDWY 0
  • Target Price
  • SILO N/A
  • LDWY N/A
  • AVG Volume (30 Days)
  • SILO 9.1M
  • LDWY 5.6K
  • Earning Date
  • SILO 02-14-2025
  • LDWY 03-31-2025
  • Dividend Yield
  • SILO N/A
  • LDWY N/A
  • EPS Growth
  • SILO N/A
  • LDWY N/A
  • EPS
  • SILO N/A
  • LDWY N/A
  • Revenue
  • SILO $72,102.00
  • LDWY $31,581,000.00
  • Revenue This Year
  • SILO $1.86
  • LDWY N/A
  • Revenue Next Year
  • SILO N/A
  • LDWY N/A
  • P/E Ratio
  • SILO N/A
  • LDWY N/A
  • Revenue Growth
  • SILO N/A
  • LDWY N/A
  • 52 Week Low
  • SILO $0.77
  • LDWY $3.02
  • 52 Week High
  • SILO $4.50
  • LDWY $6.88
  • Technical
  • Relative Strength Index (RSI)
  • SILO 52.57
  • LDWY 47.81
  • Support Level
  • SILO $1.56
  • LDWY $4.13
  • Resistance Level
  • SILO $1.89
  • LDWY $4.55
  • Average True Range (ATR)
  • SILO 0.19
  • LDWY 0.22
  • MACD
  • SILO -0.05
  • LDWY -0.02
  • Stochastic Oscillator
  • SILO 27.12
  • LDWY 39.98

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: